Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Talwin addict nephropathy.

I Stachura, S Jayakumar, M Pardo

    Clinical Nephrology
    |March 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Parenteral abuse of pentazocine hydrochloride (Talwin) can lead to membranoproliferative glomerulonephritis type I. This drug-induced nephropathy is linked to immune deposits in the kidneys, potentially involving immune mechanisms.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effect of Si/Zr ratio on the catalytic behavior of Pt-Cu/Zr-SBA-15 in continuous methane dry reforming.

    RSC advances·2026
    Same author

    Design of a single particle-interferometric reflectance imaging sensor adipo-chip for obesity biomarker screening.

    Scientific reports·2025
    Same author

    Multiplex PCR assay for the rapid detection of <i>Klebsiella pneumoniae</i> pathotypes.

    Journal of medical microbiology·2025
    Same author

    Final Search for Short-Baseline Neutrino Oscillations with the PROSPECT-I Detector at HFIR.

    Physical review letters·2025
    Same author

    Intra and inter-organ communication through extracellular vesicles in obesity: functional role of obesesomes and steatosomes.

    Journal of translational medicine·2025
    Same author

    Oral In-Situ Nanoplatform with Balanced Hydrophobic-Hydrophilic Property for Transport Across Gastrointestinal Mucosa.

    AAPS PharmSciTech·2024
    Same journal

    Clinical characteristics and outcomes of adults with minimal change disease: A retrospective, cross-sectional study.

    Clinical nephrology·2026
    Same journal

    Analysis of end-stage renal disease mediated by cuproptosis-related genes.

    Clinical nephrology·2026
    Same journal

    The relationship between red cell distribution width and platelet ratio in acute kidney injury among ventilator-associated pneumonia patients: A MIMIC-IV database study.

    Clinical nephrology·2026
    Same journal

    Arterial stiffness and choroidal vascularity index in autosomal dominant polycystic kidney disease with preserved kidney function.

    Clinical nephrology·2026
    Same journal

    Antibody-drug conjugate therapy in a renal transplant patient with bladder cancer: A case report.

    Clinical nephrology·2026
    Same journal

    Epigenetic age enhances eGFR-based prediction of all-cause mortality: A cross-cohort validation of a novel risk model.

    Clinical nephrology·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Immunology
    • Toxicology

    Background:

    • Parenteral abuse of pentazocine hydrochloride (Talwin) is a known risk factor for renal complications.
    • Membranoproliferative glomerulonephritis (MPGN) is a serious kidney disease characterized by inflammation and damage to the glomeruli.

    Purpose of the Study:

    • To investigate the clinical presentation, pathological findings, and potential immune mechanisms in patients with nephropathy associated with pentazocine abuse.
    • To determine the role of immune system activation in the development of kidney damage secondary to Talwin abuse.

    Main Methods:

    • Case series analysis of three patients with a history of pentazocine hydrochloride abuse.
    • Clinical evaluation including assessment of nephrotic syndrome, hematuria, and hypertension.

    Related Experiment Videos

  • Renal biopsy with immunofluorescence and electron microscopy to examine glomerular pathology and immune deposits.
  • Serological tests to assess complement levels (C3, C4), immunoglobulin levels (IgM), and circulating immune complexes.
  • Glomerular C3 receptor studies in one patient.

    • Main Results:

    • All three patients presented with nephrotic syndrome, microscopic hematuria, and hypertension.
    • Renal biopsies revealed membranoproliferative glomerulonephritis type I with mesangial and subendothelial immunoglobulin (IgM) and complement (C1Q, C3, C4) deposits.
    • Focal reduplication of glomerular basement membranes was observed.
    • One patient showed diffuse loss of glomerular C3 receptor activity.
    • Serum studies indicated decreased C3 levels, elevated IgM, and circulating immune complexes in affected patients.

    Conclusions:

    • Parenteral pentazocine hydrochloride abuse can induce membranoproliferative glomerulonephritis type I.
    • The findings suggest that immune mechanisms, including the deposition of immunoglobulins and complement components, play a significant role in the pathogenesis of Talwin-associated nephropathy.
    • Further research is warranted to elucidate the precise immune pathways involved in drug-induced glomerulonephritis.